{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:37:46Z","timestamp":1790375866222,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":2110,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3945\/ajcn.116.142158","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:50:17Z","timestamp":1490835017000},"page":"1239-1247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B ,"],"prefix":"10.1016","volume":"105","author":[{"given":"Hoang Vi Thanh","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Jovanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Zurbau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Blanco Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Sievenpiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Au-Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Duvnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Vuksan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/ajcn.116.142158_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/69.1.30","article-title":"Cholesterol-lowering effects of dietary fiber: a meta-analysis","volume":"69","author":"Brown","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.116.142158_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1017\/S0007114511001711","article-title":"Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals","volume":"106","author":"Vuksan","year":"2011","journal-title":"Br J Nutr"},{"key":"10.3945\/ajcn.116.142158_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ajcn\/71.2.401","article-title":"Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk","volume":"71","author":"Jenkins","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.116.142158_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diacare.23.1.9","article-title":"Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial","volume":"23","author":"Vuksan","year":"2000","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.116.142158_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jep.2010.01.021","article-title":"Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E.Br","volume":"128","author":"Chua","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.3945\/ajcn.116.142158_bib6","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the substantiation of health claims related to konjac mannan (glucomannan) and reduction of body weight (ID 854, 1556, 3725), reduction of post-prandial glycaemic responses (ID 1559), maintenance of normal blood glucose concentrations (ID 835, 3724), maintenance of normal (fasting) blood concentrations of triglycerides (ID 3217), maintenance of normal blood cholesterol concentrations (ID 3100, 3217), maintenance of normal bowel function (ID 834, 1557, 3901) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1558) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006. EFSA J 2010;8(10):1798.","DOI":"10.2903\/j.efsa.2010.1798"},{"key":"10.3945\/ajcn.116.142158_bib7","unstructured":"Summary of Health Canada\u2019s assessment of a health claim about a polysaccharide complex (glucomanna, xanthan gum, sodium alginate) and cholesterol lowering [updated May 2016]. Ottawa (Canada): Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada; 2016."},{"key":"10.3945\/ajcn.116.142158_bib8","unstructured":"Summary of Health Canada\u2019s assessment of a health claim about a polysaccharide complex (glucomanna, xanthan gum, sodium alginate) and a reduction of the post-prandial blood glucose response [updated May 2016]. Ottawa (Canada): Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada;2016"},{"key":"10.3945\/ajcn.116.142158_bib9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ajcn\/88.4.1167","article-title":"Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis","volume":"88","author":"Sood","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.116.142158_bib10","doi-asserted-by":"crossref","unstructured":"Anderson TJ, Gre\u00b4goire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr., Grover S, Gupta M, et al. Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2016.","DOI":"10.1016\/j.cjca.2016.07.510"},{"key":"10.3945\/ajcn.116.142158_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cjca.2012.11.032","article-title":"2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"29","author":"Anderson","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.3945\/ajcn.116.142158_bib12","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from: www.handbook.cochrane.org."},{"issue":"7","key":"10.3945\/ajcn.116.142158_bib13","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.3945\/ajcn.116.142158_bib14","unstructured":"Guidance for Industry: evidence-based review system for the scientific evaluation of health claims - final. Silver Spring (MD): US Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition; 2009. Available from: https:\/\/www.fda.gov\/food\/guidanceregulation\/guidancedocumentsregulatoryinformation\/labelingnutrition\/ucm073332.htm."},{"issue":"5 Suppl","key":"10.3945\/ajcn.116.142158_bib15","doi-asserted-by":"crossref","first-page":"1590S","DOI":"10.1093\/ajcn\/65.5.1590S","article-title":"Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies","volume":"65","author":"Kris-Etherton","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.116.142158_bib16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jama.286.8.944","article-title":"Should immunonutrition become routine in critically ill patients? A systematic review of the evidence","volume":"286","author":"Heyland","year":"2001","journal-title":"JAMA"},{"key":"10.3945\/ajcn.116.142158_bib17","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"10.3945\/ajcn.116.142158_bib18","unstructured":"A summary of error propagation [Internet]. Cambridge (MA): Harvard University; 2007. [cited 2016 Nov 3]. Available from: http:\/\/ipl.physics.harvard.edu\/wp-uploads\/2013\/03\/PS3_Error_Propagation_sp13.pdf."},{"key":"10.3945\/ajcn.116.142158_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.3945\/ajcn.116.142158_bib20","first-page":"99","article-title":"The effect of foods containing refined konjac meal on human lipid metabolism","volume":"3","author":"Zhang","year":"1990","journal-title":"Biomed Environ Sci"},{"key":"10.3945\/ajcn.116.142158_bib21","first-page":"269","article-title":"[Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients.]","volume":"146","author":"Cairella","year":"1995","journal-title":"Clin Ter"},{"key":"10.3945\/ajcn.116.142158_bib22","unstructured":"Kaats GR, Bagchi D, Preuss HG. Konjac glucomannan dietary supplementation causes significant fat loss in compliant overweight adults. J Am Coll Nutr 2015 Oct 22 (Epub ahead of print; DOI: 10.1080\/ 07315724.2015.1009194)."},{"key":"10.3945\/ajcn.116.142158_bib23","doi-asserted-by":"crossref","unstructured":"Keithley JK, Swanson B, Mikolaitis SL, DeMeo M, Zeller JM, Fogg L, Adamji J. Safety and efficacy of glucomannan for weight loss in overweight and moderately obese adults. J Obes 2013 Dec 30 (Epub ahead of print; DOI: 10.1155\/2013\/610908).","DOI":"10.1155\/2013\/610908"},{"key":"10.3945\/ajcn.116.142158_bib24","first-page":"243","article-title":"Lipid profile and excess body weight in obese children: effect of a dietary drug supplement (glucomannan vs detastranum)","volume":"11","author":"Salvatoni","year":"1991","journal-title":"Ped Oggi"},{"key":"10.3945\/ajcn.116.142158_bib25","first-page":"135","article-title":"[Chronic use of glucomannan in the dietary treatment of severe obesity.]","volume":"83","author":"Vita","year":"1992","journal-title":"Minerva Med"},{"key":"10.3945\/ajcn.116.142158_bib26","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1093\/ajcn\/61.3.585","article-title":"Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men","volume":"61","author":"Arvill","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.116.142158_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/07315724.2003.10719273","article-title":"Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects\u2014a randomized double-blind trial","volume":"22","author":"Chen","year":"2003","journal-title":"J Am Coll Nutr"},{"key":"10.3945\/ajcn.116.142158_bib28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.nut.2013.02.010","article-title":"Could dyslipidemic children benefit from glucomannan intake?","volume":"29","author":"Guardamagna","year":"2013","journal-title":"Nutrition"},{"key":"10.3945\/ajcn.116.142158_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.numecd.2004.04.004","article-title":"Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children","volume":"15","author":"Martino","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.3945\/ajcn.116.142158_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.atherosclerosis.2013.02.005","article-title":"Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan","volume":"228","author":"Martino","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.3945\/ajcn.116.142158_bib31","first-page":"133","article-title":"Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo","volume":"28","author":"Vido","year":"1993","journal-title":"Padiatr Padol"},{"key":"10.3945\/ajcn.116.142158_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/diacare.22.6.913","article-title":"Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes: a randomized controlled metabolic trial","volume":"22","author":"Vuksan","year":"1999","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.116.142158_bib33","first-page":"289","article-title":"Effect of glucomannan on obese patients: a clinical study","volume":"8","author":"Walsh","year":"1984","journal-title":"Int J Obes"},{"key":"10.3945\/ajcn.116.142158_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.metabol.2006.08.021","article-title":"Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk","volume":"56","author":"Wood","year":"2007","journal-title":"Metabolism"},{"key":"10.3945\/ajcn.116.142158_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.ejcn.1602347","article-title":"Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes","volume":"60","author":"Yoshida","year":"2006","journal-title":"Eur J Clin Nutr"},{"key":"10.3945\/ajcn.116.142158_bib36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ejcn.2016.89","article-title":"A systematic review and meta-analysis of randomized controlled trials of the effect of barley \u03b2-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction (i-iv)","volume":"70","author":"Ho","year":"2016","journal-title":"Eur J Clin Nutr"},{"key":"10.3945\/ajcn.116.142158_bib37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S000711451600341X","article-title":"The effect of oat \u03b2-glucan on LDL-cholesterol, non-HDL-cholesterol, and apoB for CVD risk reduction: a systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"Ho","year":"2016","journal-title":"Br J Nutr"},{"issue":"5 Suppl","key":"10.3945\/ajcn.116.142158_bib38","doi-asserted-by":"crossref","first-page":"370S","DOI":"10.1080\/07315724.2001.10719170","article-title":"Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus","volume":"20","author":"Vuksan","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"10.3945\/ajcn.116.142158_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1039\/c0np00018c","article-title":"Chemistry, physico-chemistry and applications linked to biological activities of beta-glucans","volume":"28","author":"Barsanti","year":"2011","journal-title":"Nat Prod Rep"},{"key":"10.3945\/ajcn.116.142158_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004836-200603000-00015","article-title":"Colonic health: fermentation and short chain fatty acids","volume":"40","author":"Wong","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.3945\/ajcn.116.142158_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcs.2007.05.003","article-title":"Molecular aspects of cereal \u03b2-glucan functionality: physical properties, technological applications, and physiological effects","volume":"46","author":"Lazaridou","year":"2007","journal-title":"J Cereal Sci"},{"key":"10.3945\/ajcn.116.142158_bib42","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1210\/jc.2003-030087","article-title":"Insulin resistance\/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease","volume":"88","author":"Reaven","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3945\/ajcn.116.142158_bib43","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1074\/jbc.M109771200","article-title":"Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis","volume":"277","author":"Tobin","year":"2002","journal-title":"J Biol Chem"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916522048912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916522048912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3945\/ajcn.116.142158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T03:06:31Z","timestamp":1684292791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916522048912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0002916522048912"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.116.142158","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B,","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.116.142158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}